Artivion Inc (AORT)
Artivion, Inc. is a healthcare equipment and supplies company focused on medical devices and implantable human tissues used in cardiovascular and aortic care. Its product portfolio includes On-X prosthetic heart valves, aortic prostheses, hybrid stent graft systems, endovascular stent grafts, synthetic vascular grafts, and surgical sealants, along with related preservation and processing services. The company also offers technologies and products such as BioGlue, CryoValve SG, CryoPatch SG, SynerGraft, and PhotoFix, and provides pyrolytic carbon coating services. Artivion markets its products and services primarily through a direct sales organization to physicians, hospitals, and other healthcare facilities worldwide. Formerly known as CryoLife, Inc., the company adopted the Artivion name in January 2022 and was incorporated in 1984. It is headquartered in Kennesaw, Georgia, and its common stock is listed on the NYSE under the ticker AORT.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NYSE-AORT
|
$22.88
|
-9.2% Downside
|
Fair
|
$42
|
66.7% Upside
|
Bargain
|
Great
|
—
|
—
|
—
|
0.0%
|
July 30, 2026
|
105.1x
|
2.7x
|
2.7x
|
1.232 B
|
1.429 B
|
17.3%
|
94.7%
|
3.5
|
—
|
124.9%
|
